144 related articles for article (PubMed ID: 29199669)
1. Fluorodeoxyglucose-avid pulmonary mucinous adenocarcinoma presenting with nonfluorodeoxyglucose-avid cystic brain lesions of unknown etiopathology: Brain magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography-computed tomography imaging features and additional value of whole-body positron emission tomography acquisition.
Shinde V; Basu S
Indian J Cancer; 2017; 54(1):81-82. PubMed ID: 29199669
[No Abstract] [Full Text] [Related]
2. ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography in mucinous adenocarcinoma.
Murakami S; Saito H; Karino F; Kondo T; Oshita F; Ito H; Nakayama H; Yokose T; Yamada K
Eur J Radiol; 2013 Nov; 82(11):e721-5. PubMed ID: 23988690
[TBL] [Abstract][Full Text] [Related]
3. Imaging characteristics of a mucinous colorectal pulmonary metastasis.
Belcher E; Nicholson AG; Hansell DM; Goldstraw P
Ann Thorac Surg; 2008 Nov; 86(5):1698. PubMed ID: 19049786
[No Abstract] [Full Text] [Related]
4. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
5. Mucinous urachal adenocarcinoma: A potential nonfluorodeoxyglucose-avid pitfall on
Das JP; Vargas HA; Ulaner GA
World J Nucl Med; 2020; 19(4):432-434. PubMed ID: 33623517
[TBL] [Abstract][Full Text] [Related]
6. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
Yi CA; Lee KS; Lee HY; Kim S; Kwon OJ; Kim H; Choi JY; Kim BT; Hwang HS; Shim YM
Cancer; 2013 May; 119(10):1784-91. PubMed ID: 23423920
[TBL] [Abstract][Full Text] [Related]
7. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary mucinous cystadenocarcinoma: an extremely rare tumor presenting as a cystic lesion of the lung.
Iwasaki T; Kawahara K; Nagano T; Nakagawa K
Gen Thorac Cardiovasc Surg; 2007 Mar; 55(3):143-6. PubMed ID: 17447515
[TBL] [Abstract][Full Text] [Related]
9. Fluorodeoxyglucose-positron emission tomography/computed tomography imaging features of colloid adenocarcinoma of the lung: a case report.
Wang Z; Yu M; Chen Y; Kong Y
J Med Case Rep; 2017 Jul; 11(1):202. PubMed ID: 28747211
[TBL] [Abstract][Full Text] [Related]
10. Interesting image. Utility of FDG metabolism to differentiate synchronous metastatic liver lesions from synchronous colon cancer: nonmucinous versus mucinous adenocarcinoma.
Yeh CL; Chen YK
Clin Nucl Med; 2010 Jan; 35(1):44-6. PubMed ID: 20026977
[No Abstract] [Full Text] [Related]
11. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma.
Okada M; Nakayama H; Okumura S; Daisaki H; Adachi S; Yoshimura M; Miyata Y
J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1384-91. PubMed ID: 21440264
[TBL] [Abstract][Full Text] [Related]
12. Gossypiboma Mimicking Fluorodeoxyglucose-avid Lung Nodule.
Dubois RL; Raisig E; Stanifer BP
Ann Thorac Surg; 2020 Jun; 109(6):e403-e405. PubMed ID: 31760056
[TBL] [Abstract][Full Text] [Related]
13. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
Kumar R; Hawkins RA; Yeh BM; Wang ZJ
Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
[TBL] [Abstract][Full Text] [Related]
14. Isolated vertebral metastasis with a fluid-fluid level from a poorly differentiated adenocarcinoma.
Jarraya M; Hayashi D; Lebreton C; Côté JF; Guermazi A; Vallée C
Diagn Interv Radiol; 2013; 19(3):233-6. PubMed ID: 23233407
[TBL] [Abstract][Full Text] [Related]
15. The clinical value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in postoperative patients with gastrointestinal mucinous adenocarcinoma.
Yang ZY; Hu SL; Shi W; Zhu BL; Xu JY; Zhang YJ
Nucl Med Commun; 2011 Nov; 32(11):1018-25. PubMed ID: 21956489
[TBL] [Abstract][Full Text] [Related]
16. The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas.
Mansour JC; Schwartz L; Pandit-Taskar N; D'Angelica M; Fong Y; Larson SM; Brennan MF; Allen PJ
J Gastrointest Surg; 2006 Dec; 10(10):1354-60. PubMed ID: 17175454
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance diffusion-weighted imaging in the characterization of pancreatic mucinous cystic lesions.
Fatima Z; Ichikawa T; Motosugi U; Muhi A; Sano K; Sou H; Haradome H; Kiryu S; Araki T
Clin Radiol; 2011 Feb; 66(2):108-11. PubMed ID: 21216325
[TBL] [Abstract][Full Text] [Related]
18. Use of F-18 fluorodeoxyglucose positron emission tomography with dual-phase imaging to identify intraductal papillary mucinous neoplasm.
Saito M; Ishihara T; Tada M; Tsuyuguchi T; Mikata R; Sakai Y; Tawada K; Sugiyama H; Kurosawa J; Otsuka M; Uchida Y; Uchiyama K; Miyazaki M; Yokosuka O
Clin Gastroenterol Hepatol; 2013 Feb; 11(2):181-6. PubMed ID: 23142206
[TBL] [Abstract][Full Text] [Related]
19. Synchronous triple primary lung cancers: a case report.
Yoon HJ; Lee HY; Han J; Choi YL
Korean J Radiol; 2014; 15(5):646-50. PubMed ID: 25246827
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of colloid adenocarcinoma of the lung: A report of six cases.
Masai K; Sakurai H; Suzuki S; Asakura K; Nakagawa K; Watanabe S
J Surg Oncol; 2016 Aug; 114(2):211-5. PubMed ID: 27220284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
